Jed Fahey, Sc.D. on Isothiocyanates, the Nrf2 Pathway, Moringa & Sulforaphane Supplementation

Trial Design

Clinical trials exploring the effects of broccoli sprout extracts on neurological diseases are underway, with a focus on autism and schizophrenia. Jed Fahey highlights trials in the U.S. and China, examining biomarkers like IL-6 and TNF-alpha to assess symptom reduction and biochemical changes 1. These trials are crucial yet challenging, as Fahey notes the emotional and financial investments involved:

It's exciting, but it's very expensive. It's labor intensive. You've got the hopes and fears and desires and tears of a lot of people involved.

--- Jed Fahey

Despite these hurdles, the trials aim to replicate promising findings from earlier studies, offering hope for effective treatments 2.

   

Trial Outcomes

The outcomes of trials using broccoli sprout extracts are promising, particularly in reducing inflammation linked to neurological conditions. Rhonda Patrick and Jed Fahey discuss how sulforaphane impacts brain inflammation, potentially aiding conditions like autism and Alzheimer's 3. Fahey explains the trial process, including a placebo phase followed by sulforaphane administration, aiming to confirm previous findings:

Half of them are getting a placebo for, I think it's 15 weeks...and then everybody goes on the sulforaphane product.

--- Jed Fahey

These trials are essential for validating sulforaphane's effects, despite the high costs and complexities involved 4.